Smallpox | Global Biodefense

Menu

Latest stories

US Invests Additional 44 Million in Smallpox Vaccine Manufacturing

Biosecurity and Biodefense Industry News

SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox

More on pathogens and preparedness

CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine

by Global Biodefense August 12, 2018, 3:36 pm
Factoring Immunosuppression into Smallpox Outbreak Planning

by Global Biodefense April 22, 2018, 10:19 am
Lassa Fever in Nigeria, Vaccine Pills, Novichok Poisoning
Biodefense Headlines – February 21, 2018

by Stephanie Lizotte February 21, 2018, 1:47 pm
USAMRIID-Bavarian Nordic Smallpox Vaccine Phase 3 Study

by Global Biodefense February 19, 2018, 1:10 am
Biodefense Headlines – February 14, 2018

by Stephanie Lizotte February 14, 2018, 3:39 pm
U.S. Seeks to Develop Late-Stage Smallpox Antivirals
BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures

by Global Biodefense November 16, 2017, 12:49 pm
Bavarian Nordic Highlights Smallpox Orders, Vaccine Development

by Global Biodefense November 10, 2017, 8:40 am
Emergent BioSolutions to Acquire Smallpox Vaccine Business from Sanofi

by Global Biodefense July 18, 2017, 4:22 pm
Smallpox Vaccine Potency Testing
Biodefense Headlines – January 22, 2017

by Stephanie Lizotte January 22, 2017, 12:09 pm

Congratulations. You've reached the end of the internet.

Back to Top